// company-profile
Kazia Therapeutics Ltd
KZIAExchangeNasdaqSectorPharmaceutical PreparationsInc.C3Filings2Insiders2
// api This Kazia Therapeutics Ltd insider-trading data is served live by the Form4API insider trading API. Get the same data via API.
// activity-summary
Recent insider activity is bullish. Over the last 30 days, 2 insiders purchased shares. Buying was led by Levine James E..
// 90-day insight
Over the last 90 days, Kazia Therapeutics Ltd insiders bought $0 across 2 transactions with no open-market sales.
- Most active insider: Levine James E. with 1 transaction totaling $0.
Activity skews bullish — buys outpace sales.
Institutional Ownership
Top 13F-HR holders of Kazia Therapeutics Ltd as of 2026-03-31
Total reported AUM
$13.0M
QoQ change
-23.8%
Reporting period
2026-03-31
#1
Bleichroeder LP
CIK 1781002
$3.0M
400K shares
#2
Stonepine Capital Management, LLC
CIK 1440771
$2.6M
345K shares
#3
Point72 Asset Management, L.P.
CIK 1603466
$1.5M
200K shares
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 19, 2026 | Levine James E. | KZIA | Award | 200,000 | $0.00 | $0K |
| Jun 19, 2026 | Rao Sudha | KZIA | Award | 250,000 | $0.00 | $0K |
Popular companies on Form4API
Browse insider trading activity for other actively-filed companies.